JENNIFER L KOESTER

Allopathic & Osteopathic Physicians|Family Medicine LAKEVILLE, MA NPI 1407446909

General Payments — all program years on this page

$1,692.89

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 77
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $430.70 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $430.7019

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $182.6410
2022 $578.5826
2023 $500.9722
2024 $430.7019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092244760 Boston Scientific Corporation $23.18 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113473557 Kowa Pharmaceuticals America, Inc. $16.85 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117997067 Boehringer Ingelheim Pharmaceuticals, Inc. $25.78 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123302420 AstraZeneca Pharmaceuticals LP $34.51 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123308530 AstraZeneca Pharmaceuticals LP $27.94 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123308660 AstraZeneca Pharmaceuticals LP $17.32 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123310432 AstraZeneca Pharmaceuticals LP $32.59 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123310578 AstraZeneca Pharmaceuticals LP $26.05 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123311376 AstraZeneca Pharmaceuticals LP $9.47 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128383673 Exact Sciences Corporation $28.90 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128383677 Exact Sciences Corporation $24.93 12/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128383681 Exact Sciences Corporation $21.79 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130967179 PFIZER INC. $20.19 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135702415 Lilly USA, LLC $24.74 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147371872 Mylan Specialty L.P. $15.52 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151180554 Phathom Pharmaceuticals, Inc. $27.26 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153565665 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.06 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153640992 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.49 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153710206 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.13 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.